Jupiter Life Line Hospitals Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹365Cr
- +9.6% YoY
- −7.4% QoQ
- Net profit
- ₹42Cr
- −19.2% YoY
- −26.3% QoQ
- Margin
- 23%
- 0 pp YoY
- 0 pp QoQ
Guidance rank: #33 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially. New 500-bed Dombivli hospital to start operations in Q1 FY'27, expected EBITDA drag for 1-2 years before turning profitable.
From Jupiter Life Line Hospitals Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially.
- New hospitals like Dombivli expected to take 2-3 years for stabilization; breakeven anticipated by end of year 2 with EBITDA drag initially.
- Occupancy growth limited in mature hospitals (e.g., Thane), moderate in Pune, and strong growth opportunity in Indore.
- Industry-wide demand-supply mismatch with insufficient high-quality tertiary care supply; growth story expected to continue for multiple decades.
- Jupiter plans to expand beyond existing 6 hospitals, committed to Western India, and intends to grow alongside supply.
- Insurance renewals are inflation-linked but negotiated annually; uncertain long-term margin impact due to potential wage and cost increases.
2 more points from Jupiter Life Line Hospitals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Jupiter Life Line Hospitals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Pune Bibvewadi project: Construction has started, currently at basement work stage; excavation completed. Expected to begin operations in calendar year 2028. Capex incurred so far is around INR 45 crores.
- Dombivli hospital: Completed construction of 500-bed hospital at INR 425 crores capex. Launch planned for February 15, 2026, with phased bed activation starting from 200 beds. EBITDA drag expected for ~2 years before profitability.
- Mira Road project: Regulatory approvals in progress; construction not yet started; no capex incurred yet.
2 more points from Jupiter Life Line Hospitals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Jupiter Life Line Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Jupiter Life Line Hospitals Ltd said on order book & pipeline — free account, 30 seconds.
Jupiter Life Line Hospitals Ltd — Quarterly revenue & net profit
Jupiter Life Line Hospitals Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 365 | 333 | +9.6% | 394 | -7.4% |
| Operating profit (EBITDA) | 83 | 76 | +9.2% | 92 | -9.8% |
| Operating margin | 23% | 23% | 0 pp | 23% | 0 pp |
| Profit before tax | 57 | 67 | -14.9% | 74 | -23% |
| Net profit (PAT) | 42 | 52 | -19.2% | 57 | -26.3% |
| EPS (₹) | 1.30 | 1.59 | -18.2% | 1.75 | -25.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹456 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jupiter Life Lin's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnostic Centre's Q3 FY26 earnings call —
- Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
- Chandan Healthca (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
- Rainbow Childrens Medicare (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Jupiter Life Line Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Jupiter Life Line Hospitals Ltd Q3 FY26 results?
Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially. New 500-bed Dombivli hospital to start operations in Q1 FY'27, expected EBITDA drag for 1-2 years before turning profitable.
What is Jupiter Life Line Hospitals Ltd share price analysis?
Jupiter Life Line Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 54.1 with a market cap of ₹10,351 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jupiter Life Line Hospitals Ltd planning capital expenditure?
Pune Bibvewadi project: Construction has started, currently at basement work stage; excavation completed.
Keep Jupiter Life Line Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
